IP Library Granted Patent US 9,114,124
Granted Patent B2
US 9,114,124 · App. 14/583,365 · Granted Aug 25, 2015

Modulation of nerves innervating the liver

Inventors: Bobak Robert Azamian (Newport Coast, CA); Jonathan Allen Coe (Menlo Park, CA); Scott Bradley Vafai (Boston, MA)
Assignee: Metavention, Inc.
A61K33/30A61B17/00A61B17/00234A61B17/32A61B17/320068A61B18/02A61B18/04A61B18/06A61B18/1492A61B18/18A61B18/1815A61B18/20A61K31/045A61K31/05A61K31/395A61K45/06A61M5/14A61N5/00A61N7/00A61B18/24A61B2017/00318A61B2018/0022A61B2018/00023A61B2018/00214A61B2018/00404A61B2018/00434A61B2018/00529A61B2018/00577A61B2018/00791A61B2018/00839A61B2018/0212A61B2018/048A61B2018/1861A61N7/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,114,124
App. No.
14/583,365
Granted
Aug 25, 2015
Kind
B2
Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.

Claims (47)

1. A method of facilitating hepatic neuromodulation in a subject, comprising:

positioning an energy delivery device at a location to deliver energy to sympathetic nerves that innervate a liver of the subject and

delivering energy to the sympathetic nerves, using the energy delivery device, sufficient to ablate the sympathetic nerves in a manner that facilitates a reduction in at least one of a blood glucose level or a lipoprotein level in the subject,

wherein the delivered energy is radiofrequency energy having a frequency between 50 kHz and 5 MHz,

wherein the delivered energy heats the sympathetic nerves to a temperature of up to 90 degrees Celsius; and

wherein the sympathetic nerves are sympathetic nerves of a hepatic plexus.

2. The method of claim 1 , wherein the step of positioning the energy delivery device comprises advancing a distal end of the energy delivery device to a position within a common hepatic artery of the subject.

3. The method of claim 1 , wherein the step of positioning the energy delivery device comprises advancing a distal end of the energy delivery device to a position within a portion of a hepatic artery of the subject.

4. The method of claim 1 , wherein delivering energy to the sympathetic nerves comprises delivering energy sufficient to ablate nerves innervating a pancreas or a small intestine.

5. The method of claim 2 ,

wherein the step of advancing a distal end of the energy delivery device to a position within the common hepatic artery of the subject comprises inserting the energy delivery device into vasculature using a percutaneous intravascular incision approach,

wherein the sympathetic nerves are within an adventitia of the common hepatic artery,

wherein the energy delivery device comprises a radiofrequency catheter having at least one electrode positioned at the distal end of the energy delivery device, and

wherein the energy is delivered to the sympathetic nerves having a frequency between 100 kHz and 2.5 MHz.

6. The method of claim 1 , further comprising confirming said ablation of the sympathetic nerves.

7. A method of facilitating hepatic neuromodulation in a subject, comprising:

positioning an energy delivery device at a location to deliver energy to sympathetic nerves that innervate a liver of the subject and

delivering energy to the sympathetic nerves, using the energy delivery device, sufficient to denervate the sympathetic nerves in a manner that facilitates a reduction in at least one of a glucose level or a lipoprotein level in the subject in the subject,

wherein the sympathetic nerves are sympathetic nerves of a hepatic plexus.

8. The method of claim 7 , wherein the location is within a portion of a hepatic artery of the subject.

9. The method of claim 8 , wherein the portion of the hepatic artery is the common hepatic artery.

10. The method of claim 7 , wherein the energy is delivered transcutaneously.

11. The method of claim 10 , wherein the delivered energy has a frequency between 20 kHz and 20 MHz.

12. The method of claim 7 , wherein the delivered energy is radiofrequency energy having a frequency between 50 kHz and 5 MHz.

13. The method of claim 7 , further comprising confirming said denervation of the sympathetic nerves.

14. The method of claim 7 , further comprising delivering energy to nerves that innervate at least one of a pancreas and a small intestine.

15. The method of claim 7 ,

wherein the step of positioning the energy delivery device comprises advancing a distal end of the energy delivery device to a position within a common hepatic artery of the subject using a percutaneous intravascular incision approach,

wherein the sympathetic nerves are within an adventitia of the common hepatic artery,

wherein the energy delivery device comprises a radiofrequency catheter having at least one electrode positioned at the distal end, and

wherein the energy is delivered to the sympathetic nerves at a frequency between 100 kHz and 2.5 MHz.

16. A method of facilitating hepatic neuromodulation in a subject, comprising:

positioning an energy delivery device at a location to deliver energy to nerves that innervate a liver of the subject; and

causing energy to be delivered to the nerves using the energy delivery device, the energy being sufficient to ablate the nerves in a manner that facilitates a reduction in at least one of a glucose level or a lipoprotein level in the subject,

wherein the nerves comprise nerves surrounding a hepatic artery of the subject.

17. The method of claim 16 , wherein the location is within a portion of a hepatic artery of the subject.

18. The method of claim 16 , wherein the energy is delivered transcutaneously.

19. The method of claim 17 ,

wherein the portion of the hepatic artery is the common hepatic artery,

wherein the delivered energy has a frequency between 100 kHz and 2.5 MHz,

wherein the energy delivery device comprises at least one radiofrequency electrode,

wherein the at least one radiofrequency electrode is configured to maintain contact with a wall of the common hepatic artery at a contact pressure of between 0.1 g/mm 2 and 10 g/mm 2 ,

wherein the nerves are sympathetic nerves of the hepatic plexus, and

wherein the energy is delivered to heat the sympathetic nerves in the hepatic plexus to a temperature of up to 90 degrees Celsius and sufficient to cause ablation of the sympathetic nerves.

20. The method of claim 18 ,

wherein the delivered energy has a frequency between 20 kHz and 20 MHz, and

wherein the nerves are sympathetic nerves of the hepatic plexus.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2023
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 064987/0161 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2023
From: CUSTOMERS BANK (SUCCESSOR IN INTEREST TO SIGNATURE BANK)
To: METAVENTION, INC.
Reel/Frame 064670/0039 →
SECURITY INTEREST Recorded Jan 11, 2023
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 062349/0859 →
SECURITY INTEREST Recorded Oct 31, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 061602/0249 →
SECURITY INTEREST Recorded Jun 29, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 060358/0417 →
SECURITY INTEREST Recorded Dec 20, 2021
From: METAVENTION, INC.
To: SIGNATURE BANK
Reel/Frame 058433/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2017
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 041986/0324 →
Continuity (5)
Continuation 14075908 · Nov 8, 2013
Continuation 13789509 · Mar 7, 2013
Continuation PCTUS2012068630 · Dec 7, 2012
Provisional Application 61568843 · Dec 9, 2011
Related Publication 20150112332A1 · Apr 23, 2015